W

Moderna’s stock doubles on promising cancer-vaccine results

Business Management
Share
Moderna’s stock doubles on promising cancer-vaccine results

The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.

Moderna’s stock doubles on promising cancer-vaccine results

Source：MarketWatch

Disclaimer：Please read market information rationally and stay aware of investment risks. All content on this site is for informational purposes only and does not constitute investment advice.

Related Reading

Why renters are obsessed with these $300 ‘boneless couches’

Black Friday could be the perfect time to buy one. Source：MarketWatch

A Bitcoin block just neared a 2015 transaction record, but paid only $180 in fees

The AntPool block came within 984 transactions of Bitcoin’s 2015 record, even as fees made up less than 0.1% of the miner’s payout. Source：CoinDesk

How SpaceX was able to avert one of the market’s biggest fears about its stock

Some investors worried that SpaceX’s volatile stock would have an extreme impact on indexes, but the company’s staggered lockup schedule has mitigated this…

Google’s AI chip push adds more pressure on Nvidia

Google’s specialised AI chips threaten greater competition as Nvidia faces a leadership investigation. Source：CoinDesk

Source：https://www.marketwatch.com/story/modernas-stock-doubles-on-promising-cancer-vaccine-results-896b1f2c